£699

This is a comprehensive review of the patent portfolios of Jazz Pharmaceuticals Ltd. (split into those held by GW Research Ltd., and those held by GW Pharmaceuticals Ltd.), and of six other leading companies involved in patenting activity for the medical application of cannabis and cannabinoids.

The dataset consists of unique patent families or “novel inventions” - meaning the same patent filed in multiple locations or at different times.The date shown is that at which the first patent in each patent family is believed to have been applied for. There are no URLs or links to the patents included in the dataset.

Key terms related to these patents were extrapolated from analysing their content, and in each case, the terms which are relevant to each individual patent family are marked. Examples of key terms include: CBD, CBDA, CBDV, THC, THCA, THCV, Epilepsy, Neuroprotection, Neurodegeneration, Arthritis, CBD Analogue, Manufacturing Methodology, Novel Compound, Brain Injury etc.

This data is formatted in an Excel spreadsheet (.xls) and will be sent to you via email.